PRA Health Sciences, Inc.(NasdaqGS:PRAH) dropped from S&P 400 Health Care

PRA Health Sciences, Inc. is a United States-based company. The Company is a contract research organization. It is engaged in providing outsourced clinical development and data solution services to the biotechnology and pharmaceutical industries. The Company focused on oncology, immunology, central nervous system, inflammation, respiratory, cardiometabolic, and infectious diseases. It operates through two segments: Clinical Research and Data Solutions. The Clinical Research segment provides services across the spectrum of clinical development programs. The Data Solutions segment provides data, analytics, technology and consulting solutions to the life sciences market. The Company offer clinical development service offerings, which include functional outsourcing services, traditional and project based clinical trial services.